As of 6 Nov 2026, Welcure Drugs and Pharmaceuticals is loss-making on a trailing 12-month basis, with a net loss of ₹5.49 Cr, so it has no P/E ratio. The share price is ₹0.18, 72% below its 52-week high. It is a small-cap company with a market cap of ₹22 Cr, ranked 8th of 11 Medical Distribution companies by market cap; the shares fell 63% over the past year.
- ₹0.19
- ₹0.19
- ₹0.18
- ₹0.19
- 25.7 L
Health check
- ReturnsBehind
−62.7% over a year, better than 0 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- Growthn/a
Not enough yearly results to measure.
- ProfitabilityNegative
ROCE -5.7% vs peer median 9.4%.
- Balance sheetStretched
Piotroski 3 of 9.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹22 Cr
- Small cap
- P/E
- n/a
- Industry 36.7
- Price to book
- 0.23
- Peers 2.10
- Dividend yield
- 0.00%
- ROE
- −5.5%
- Peers 8.0%
- ROCE
- −5.7%
- Peers 9.4%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- −₹0.04
- OPM (TTM)
- −1.5%
- Net margin −1.5%
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- −2062.4%
- Latest quarter vs a year ago
- Price to sales
- 0.06
- EV/EBITDA −4.0
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −5.5%.
- Quarterly profit down 2062.4% on a year ago.
- 72% below its 52-week high.
About Welcure Drugs and Pharmaceuticals
Welcure Drugs and Pharmaceuticals Limited engages in trading of medical products in India. The company offers pharmaceutical and agri-tech development solutions. It also imports and exports its products. Welcure Drugs and Pharmaceuticals Limited was incorporated in 1996 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad
- Sector
- Healthcare
- ISIN
- INE331C01025
- Website
- welcure.co.in
Price range
- Avg volume (3M)
- 53.6 L
- 1-year return
- minus 62.7%
- From 52-week high
- minus 71.9%
Peers · Medical Distribution
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTEROEntero Healthcare Solutions | 1,900.40 | plus 8.34% | 8,279 | 66.0 | 4.90 | 11.3% | 6.7% | 4.4% | 25.7% | – | 0.00% | plus 62.4% |
| APPLAptus Pharma | 465.00 | plus 0.92% | 797 | 100.2 | 28.06 | 29.3% | 31.7% | 15.4% | 49.6% | 187.5% | 0.00% | plus 772.6% |
| ARVAYAArvaya Healthcare | 111.00 | minus 4.31% | 576 | – | – | 1.4% | 2.2% | 0.0% | 193.6% | – | 0.00% | plus 143.1% |
| EVEXIAEvexia Lifecare | 1.46 | minus 3.31% | 274 | 146.0 | 0.67 | 0.3% | 0.3% | 1.6% | 16.6% | 34.5% | 0.00% | minus 15.2% |
| NOVELIXNovelix Pharmaceuticals | 64.66 | minus 4.91% | 184 | 36.7 | 2.93 | 7.4% | 8.0% | 3.1% | 354.8% | – | 0.00% | plus 29.5% |
| AMWILLAmwill Health Care | 44.00 | plus 5.67% | 88 | 7.8 | 1.06 | 15.5% | 14.4% | 14.1% | 14.7% | 54.2% | 2.27% | minus 25.4% |
| CBPLChandra Bhagat Pharma | 55.50 | minus 4.31% | 42 | 13.7 | 1.26 | – | 9.7% | 2.5% | – | – | 0.00% | plus 45.0% |
| WELCUREWelcure Drugs and Pharmaceuticals | 0.18 | minus 5.26% | 22 | – | 0.23 | −5.7% | −5.5% | −1.5% | – | – | 0.00% | minus 62.7% |
| Median of 7 peers | – | −3.31% | 274 | 51.4 | 2.10 | 9.4% | 8.0% | 3.1% | 37.7% | 54.2% | 0.00% | 45.0% |
Quarterly results
| ₹ Cr | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 |
|---|---|---|---|---|---|
| 21.2 | 300 | 65.6 | – | – | |
| 20.6 | 269 | 54.3 | – | – | |
| 0.6 | 31.1 | 11.4 | −0 | −49.9 | |
| 3.0% | 10.4% | 17.3% | – | – | |
| 1.9 | 0 | 0 | 1.5 | 0 | |
| 0 | 0 | 0 | 0 | – | |
| 2.5 | 31.1 | 11.4 | 1.4 | −49.9 | |
| – | 25.2% | 25.2% | 25.2% | – | |
| 2.5 | 23.3 | 8.5 | 1.1 | −49.9 | |
| 0.33 | 2.07 | 0.07 | 0.13 | -0.40 |
Profit & loss
- ROE
- −5.5%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| – | – | 24.6 | 366 | |
| – | – | 23.7 | 372 | |
| −0.1 | −0.2 | 0.9 | −6.9 | |
| – | – | 3.6% | −1.9% | |
| 0 | 0.1 | 1.9 | 1.5 | |
| 0 | 0 | 0 | 0 | |
| 0.2 | −0 | – | – | |
| 0.1 | −0.2 | 2.8 | −5.5 | |
| – | – | 21.9% | – | |
| 0.1 | −0.2 | 2.2 | −5.5 | |
| – | minus 271.9% | – | minus 353.0% | |
| 0.01 | -0.01 | 0.36 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 13.4 | 13.4 | 112 | 124 | |
| −11.9 | −12.1 | −9.9 | −26.6 | |
| – | – | 123 | – | |
| 0 | 0 | 41.3 | 413 | |
| 1.5 | 1.4 | 267 | 510 | |
| 0.1 | 0 | 0 | 0 | |
| 0.2 | – | – | 1.3 | |
| 0 | 0 | 0.1 | 0.6 | |
| 1.3 | 1.3 | 267 | 508 | |
| 1.5 | 1.4 | 267 | 510 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.1 | −0.1 | −222 | 1.7 | |
| – | 0.2 | −0.1 | −1.3 | |
| −0.2 | −0 | 222 | – | |
| −0.1 | 0 | 0.1 | 0.4 | |
| – | – | −0 | – | |
| 0.1 | −0.1 | −222 | 1.7 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.